Molecular Targets in Bronchopulmonary Dysplasia

支气管肺发育不良的分子靶点

基本信息

  • 批准号:
    6947727
  • 负责人:
  • 金额:
    $ 25.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-09-01 至 2007-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objectives are to better understand the progression of events leading to the development of bronchopulmonary dysplasia (BPD) in premature neonates requiring mechanical ventilation, and to test the efficacy of retinoid treatments in preventing the development of BPD. The premature lung is structurally immature and is subject to injury at the cellular and architectural levels when subjected to the mechanical forces of ventilation. Stretch-mediated injury blocks the normal developmental pattern of the neonatal lung and results in loss of gas-exchange capacity. Previous studies have shown that the structural protein elastin is required for alveolar development and is abnormally assembled into fibers in the BPD lung, and that the alveolar myofibroblast phenotype and distribution is altered in BPD. Retinoids are currently being tested in human trials for efficacy in abating lung injury in the ventilated premature neonate at risk for BPD, and are known to regulate elastin gene expression in the developing lung. The first specific aim of this proposal is to test the efficacy of retinoids in attenuating the development of BPD in the baboon model of BPD, and to determine the effects of retinoids on elastic fiber deposition and assembly in the ventilated premature neonate. This model offers highly controlled treatment regimens and therefore can be used to critically test therapeutic modalities. Preterm baboon fetuses delivered at 125 d of gestation will be assigned to retinoid treatment or vehicle and then subjected to the standard treatments for 6-14 days. Physiologic indices, morphometric analysis of lung structure, and molecular analyses of elastic fiber assembly and injury will be used to assess retinoid effects. The second aim is to determine the effects of other experimental treatments on alveolar myofibroblast distribution and elastic fiber assembly, as we propose these are important indices of alveolar development. The third aim is to use gene array technology to identify changes in gene expression resulting from mechanical ventilation, and to "mine" gene expression profiles with the goal of developing a molecular signature for BPD. This aim will also identify genes with expression profiles associated with alveolar development, and downstream targets of specific therapies for BPD. These studies will be highly interactive within the Consortium and provide gene expression data for the scientific community at large.
描述(由申请人提供): 长期目标是更好地了解导致需要机械通气的早产儿发生支气管肺发育不良(BPD)的事件进展,并测试类维生素A治疗预防BPD发生的疗效。早产儿肺在结构上不成熟,当受到通气的机械力时,在细胞和结构水平上受到损伤。牵张介导的损伤阻断了新生儿肺的正常发育模式,并导致气体交换能力的丧失。以前的研究表明,结构蛋白弹性蛋白是肺泡发育所需的,并在BPD肺中异常组装成纤维,并且肺泡肌成纤维细胞表型和分布在BPD中改变。目前正在人体试验中测试类维生素A在减轻有BPD风险的通气早产儿肺损伤方面的功效,并且已知类维生素A调节发育中的肺中的弹性蛋白基因表达。本提案的第一个具体目的是测试类维生素A在减弱狒狒BPD模型中BPD发展的功效,并确定类维生素A对通气早产儿弹性纤维沉积和组装的影响。该模型提供高度受控的治疗方案,因此可用于严格测试治疗方式。将在妊娠125天分娩的早产狒狒胎仔分配至类维生素A处理组或溶媒组,然后进行6-14天的标准处理。生理指标、肺结构的形态测定分析以及弹性纤维组装和损伤的分子分析将用于评估类维生素A的作用。第二个目的是确定其他实验治疗对肺泡肌成纤维细胞分布和弹性纤维组装的影响,因为我们提出这些是肺泡发育的重要指标。第三个目标是使用基因阵列技术来识别机械通气引起的基因表达变化,并“挖掘”基因表达谱,目标是开发BPD的分子特征。这一目标还将确定与肺泡发育相关的表达谱基因,以及BPD特异性治疗的下游靶点。这些研究将在联合会内部高度互动,并为整个科学界提供基因表达数据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard A Pierce其他文献

Richard A Pierce的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard A Pierce', 18)}}的其他基金

2011 Elastin and Elastic Fibers GRS GRC
2011 弹性蛋白和弹性纤维 GRS GRC
  • 批准号:
    8205317
  • 财政年份:
    2011
  • 资助金额:
    $ 25.99万
  • 项目类别:
Elastin and Elastic Fibers
弹性蛋白和弹性纤维
  • 批准号:
    7743887
  • 财政年份:
    2009
  • 资助金额:
    $ 25.99万
  • 项目类别:
MOLECULAR TARGETS IN BPD
BPD 中的分子靶标
  • 批准号:
    7716093
  • 财政年份:
    2008
  • 资助金额:
    $ 25.99万
  • 项目类别:
MOLECULAR TARGETS IN BPD
BPD 中的分子靶标
  • 批准号:
    7562476
  • 财政年份:
    2007
  • 资助金额:
    $ 25.99万
  • 项目类别:
LUNG ELASTIN IN BRONCHOPULMONARY DYSPLASIA
支气管肺发育不良中的肺弹性蛋白
  • 批准号:
    7562422
  • 财政年份:
    2007
  • 资助金额:
    $ 25.99万
  • 项目类别:
Tissue and Cell Processing Core
组织和细胞处理核心
  • 批准号:
    8889186
  • 财政年份:
    2006
  • 资助金额:
    $ 25.99万
  • 项目类别:
Detection: Lung Imaging and Profiling
检测:肺部成像和分析
  • 批准号:
    7231245
  • 财政年份:
    2006
  • 资助金额:
    $ 25.99万
  • 项目类别:
Tissue and Cell Processing Core
组织和细胞处理核心
  • 批准号:
    8701221
  • 财政年份:
    2006
  • 资助金额:
    $ 25.99万
  • 项目类别:
Core--Field Logistics and Development
核心--现场物流与开发
  • 批准号:
    7131158
  • 财政年份:
    2006
  • 资助金额:
    $ 25.99万
  • 项目类别:
LUNG ELASTIN IN BRONCHOPULMONARY DYSPLASIA
支气管肺发育不良中的肺弹性蛋白
  • 批准号:
    7349770
  • 财政年份:
    2006
  • 资助金额:
    $ 25.99万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 25.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 25.99万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 25.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 25.99万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 25.99万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 25.99万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 25.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 25.99万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 25.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 25.99万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了